What do you think these recommedations are going to be?
"For patients on OMONTYS®, we recommend continued use of the agent as it has been providing effective anemia management."
"The vast majority of patients who are receiving the medication on an ongoing monthly basis are tolerating it well."
"As many of you have become quite comfortable with the medication, physicians and facilities that have been using OMONTYS® who wish to continue prescribing it for new patients may choose to do so."
"To date, we have seen infrequent allergic reactions in our patient population receiving their first dose of OMONTYS®. Most of these reactions have been mild..."
This pause in the use of omontys was expected. Wait a week or so for the recommendations. If you sell now you are being fooled.